Proven. Flexible.
A Range of License Options to Meet Your Specific Needs
A majority of the world’s top-15 pharmaceutical companies have licensed and are using the AlivaMab Mouse for antibody drug discovery at more than a dozen sites. In addition to the world’s largest biopharmaceutical companies, Ablexis is now offering flexible, attractive licensing terms to smaller public and private biotechnology companies.
Ablexis offers non-exclusive licensing models that include:
- Renewable, annual
- Individual target
- Perpetual
OUR PARTNERS INCLUDE
